Kazia Therapeutics Limited (KZIA): Price and Financial Metrics

Kazia Therapeutics Limited (KZIA): $5.52

0.12 (+2.22%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add KZIA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#246 of 328

in industry

KZIA Price/Volume Stats

Current price $5.52 52-week high $15.80
Prev. close $5.40 52-week low $1.87
Day low $5.40 Volume 36,800
Day high $5.76 Avg. volume 446,770
50-day MA $4.17 Dividend yield N/A
200-day MA $3.47 Market Cap 14.55M

KZIA Stock Price Chart Interactive Chart >


Kazia Therapeutics Limited (KZIA) Company Bio


Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements with St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. Kazia Therapeutics Limited has collaboration with Dana-Farber Cancer Institute to investigate the use of Kazia's investigational new drug, paxalisib, in primary central nervous system lymphoma; and Kintara Therapeutics, Inc. for the activation of paxalisib and VAL-083. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.


KZIA Latest News Stream


Event/Time News Detail
Loading, please wait...

KZIA Latest Social Stream


Loading social stream, please wait...

View Full KZIA Social Stream

KZIA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Continue Researching KZIA

Want to see what other sources are saying about Kazia Therapeutics Ltd's financials and stock price? Try the links below:

Kazia Therapeutics Ltd (KZIA) Stock Price | Nasdaq
Kazia Therapeutics Ltd (KZIA) Stock Quote, History and News - Yahoo Finance
Kazia Therapeutics Ltd (KZIA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!